Functional characterization of CYP2D6 enhancer polymorphisms

Human Molecular Genetics

Volumn 24, Issue 6, 2015, Pages 1556-1562

  Wang, Danxin ^a   Papp, Audrey C ^a   Sun, Xiaochun ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2D6; E1A ASSOCIATED P300 PROTEIN; MESSENGER RNA;

ADULT; ALLELE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CONTROLLED STUDY; ENHANCER REGION; ENZYME ANALYSIS; FEMALE; FUNCTIONAL GENOMICS; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENETIC VARIABILITY; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LIVER CELL CULTURE; MALE; MIDDLE AGED; NEXT GENERATION SEQUENCING; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONFORMATION; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC TRANSCRIPTION; GENETICS; LIVER CELL; METABOLISM;

ADULT; CYTOCHROME P-450 CYP2D6; ENHANCER ELEMENTS, GENETIC; FEMALE; HEPATOCYTES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION, GENETIC;

EID: 84936125162     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu566     Document Type: Article

References (23)

1. Phillips, K.A., Veenstra, D.L., Oren, E., Lee, J.K. and Sadee, W. (2001) Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA, 286, 2270-2279.
2. Griese, E.U., Zanger, U.M., Brudermanns, U., Gaedigk, A., Mikus, G., Morike, K., Stuven, T. and Eichelbaum, M. (1998) Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population. Pharmacogenetics, 8, 15-26.
3. Gaedigk, A., Simon, S.D., Pearce, R.E., Bradford, L.D., Kennedy, M.J. and Leeder, J.S. (2008) The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype. Clin. Pharmacol. Ther., 83, 234-242.
4. Crews, K.R., Gaedigk, A., Dunnenberger, H.M., Klein, T.E., Shen, D.D., Callaghan, J.T., Kharasch, E.D. and Skaar, T.C. (2012) Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype. Clin. Pharmacol. Ther., 91, 321-326.
5. Hicks, J.K., Swen, J.J., Thorn, C.F., Sangkuhl, K., Kharasch, E.D., Ellingrod, V.L., Skaar, T.C., Muller, D.J., Gaedigk, A. and Stingl, J.C. (2013) Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. Clin. Pharmacol. Ther., 93, 402-408.
6. Crews, K.R., Gaedigk, A., Dunnenberger, H.M., Leeder, J.S., Klein, T.E., Caudle, K.E., Haidar, C.E., Shen, D.D., Callaghan, J.T., Sadhasivam, S. et al. (2014) Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. Clin. Pharmacol. Ther., 95, 376-382.
7. Wang, D., Poi, M.J., Sun, X., Gaedigk, A., Leeder, J.S. and Sadee, W. (2014) Common CYP2D6 polymorphisms affecting alternative splicing and transcription: long-range haplotypes with two regulatory variants modulate CYP2D6 activity. Hum. Mol. Genet., 23, 268-278.
8. Simonis, M., Klous, P., Splinter, E., Moshkin, Y., Willemsen, R., deWit, E., van Steensel, B. and de Laat, W. (2006)Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4C). Nat. Genet., 38, 1348-1354.
9. Keene, M.A., Corces, V., Lowenhaupt, K. and Elgin, S.C. (1981) DNase I hypersensitive sites in Drosophila chromatin occur at the 5' ends of regions of transcription. Proc. Natl. Acad. Sci. USA, 78, 143-146.
10. McGhee, J.D., Wood, W.I., Dolan, M., Engel, J.D. and Felsenfeld, G. (1981) A 200 base pair region at the 5' end of the chicken adult beta-globin gene is accessible to nuclease digestion. Cell, 27, 45-55.
11. Maurano, M.T., Humbert, R., Rynes, E., Thurman, R.E., Haugen, E., Wang, H., Reynolds, A.P., Sandstrom, R., Qu, H., Brody, J. et al. (2012) Systematic localization of common disease-associated variation in regulatory DNA. Science, 337, 1190-1195.
12. Rao, S., Procko, E. and Shannon, M.F. (2001) Chromatin remodeling, measured by a novel real-time polymerase chain reaction assay, across the proximal promoter region of the IL-2 gene. J. Immunol., 167, 4494-4503.
13. Schadt, E.E., Molony, C., Chudin, E., Hao, K., Yang, X., Lum, P.Y., Kasarskis, A., Zhang, B., Wang, S., Suver, C. et al. (2008) Mapping the genetic architecture of gene expression in human liver. PLoS Biol., 6, e107.
14. Yang, X., Zhang, B., Molony, C., Chudin, E., Hao, K., Zhu, J., Gaedigk, A., Suver, C., Zhong, H., Leeder, J.S. et al. (2010) Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome. Res., 20, 1020-1036.
15. Kleinjan, D.A. and van Heyningen, V. (2005) Long-range control of gene expression: emerging mechanisms and disruption in disease. Am. J. Hum. Genet., 76, 8-32.
16. Dean, A. (2006) On a chromosome far, far away: LCRs and gene expression. Trends Genet., 22, 38-45.
17. Sanyal, A., Lajoie, B.R., Jain, G. and Dekker, J. (2012) The longrange interaction landscape of gene promoters. Nature, 489, 109-113.
18. Lower, K.M., Hughes, J.R., De Gobbi, M., Henderson, S., Viprakasit, V., Fisher, C., Goriely, A., Ayyub, H., Sloane-Stanley, J., Vernimmen, D. et al. (2009) Adventitious changes in longrange gene expression caused by polymorphic structural variation and promoter competition. Proc. Natl Acad. Sci. USA, 106, 21771-21776.
19. Simonis, M., Kooren, J. and de Laat, W. (2007) An evaluation of 3C-based methods to capture DNA interactions. Nat. Methods, 4, 895-901.
20. van de Werken, H.J., Landan, G., Holwerda, S.J., Hoichman, M., Klous, P., Chachik, R., Splinter, E., Valdes-Quezada, C., Oz, Y., Bouwman, B.A. et al. (2012) Robust 4C-seq data analysis to screen for regulatory DNA interactions. Nat.Methods, 9, 969-972.
21. Fullwood, M.J., Wei, C.L., Liu, E.T. and Ruan, Y. (2009) Nextgeneration DNA sequencing of paired-end tags (PET) for transcriptome and genome analyses. Genome Res., 19, 521-532.
22. Shalem, O., Sanjana, N.E., Hartenian, E., Shi, X., Scott, D.A., Mikkelsen, T.S., Heckl, D., Ebert, B.L., Root, D.E., Doench, J.G. et al. (2014) Genome-scale CRISPR-Cas9 knockout screening in human cells. Science, 343, 84-87.
23. Wang, D., Papp, A.C., Binkley, P.F., Johnson, J.A. and Sadee, W. (2006) Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissues. Pharmacogenet. Genomics, 16, 735-745.